These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37634281)

  • 1. BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer.
    Ottaiano A; Santorsola M; Circelli L; Ianniello M; Casillo M; Petrillo N; Sabbatino F; Cascella M; Perri F; Capuozzo M; Albino V; Granata V; Izzo F; Di Mauro A; Berretta M; Ruggiero R; Gualillo O; Sirica R; Nasti G; Savarese G
    Neoplasia; 2023 Oct; 44():100930. PubMed ID: 37634281
    [No Abstract]   [Full Text] [Related]  

  • 2. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
    Affolter K; Samowitz W; Tripp S; Bronner MP
    Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
    Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
    Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic pattern is a prognostic factor in BRAF
    Ji J; Sandhu J; Wang C; Fakih M
    Cancer Treat Res Commun; 2023; 35():100714. PubMed ID: 37126990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers.
    Tang Z; Yuan X; Du R; Cheung SH; Zhang G; Wei J; Zhao Y; Feng Y; Peng H; Zhang Y; Du Y; Hu X; Gong W; Liu Y; Gao Y; Liu Y; Hao R; Li S; Wang S; Ji J; Zhang L; Li S; Sutton D; Wei M; Zhou C; Wang L; Luo L
    Mol Cancer Ther; 2015 Oct; 14(10):2187-97. PubMed ID: 26208524
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Garcia-Carbonero N; Martinez-Useros J; Li W; Orta A; Perez N; Carames C; Hernandez T; Moreno I; Serrano G; Garcia-Foncillas J
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952366
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer.
    Akhoundova D; Pietge H; Hussung S; Kiessling M; Britschgi C; Zoche M; Rechsteiner M; Weber A; Fritsch RM
    JCO Precis Oncol; 2021 Nov; 5():1082-1087. PubMed ID: 34994629
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvements in Clinical Outcomes for
    Morris VK; Bekaii-Saab T
    Clin Cancer Res; 2020 Sep; 26(17):4435-4441. PubMed ID: 32253230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
    Osumi H; Shinozaki E; Wakatsuki T; Suenaga M; Ichimura T; Ogura M; Takahari D; Ooki A; Suzuki T; Ota Y; Nakayama I; Chin K; Miki Y; Yamaguchi K
    Int J Cancer; 2019 Nov; 145(9):2488-2495. PubMed ID: 30963570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based Screening for
    Chu JE; Johnson B; Kugathasan L; Morris VK; Raghav K; Swanson L; Lim HJ; Renouf DJ; Gill S; Wolber R; Karsan A; Kopetz S; Schaeffer DF; Loree JM
    Clin Cancer Res; 2020 Sep; 26(17):4599-4605. PubMed ID: 32571791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biomarker of response to therapy in metastatic BRAF
    Nat Med; 2022 Oct; 28(10):2015-2016. PubMed ID: 36104595
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test].
    Jöhrens K; Fischer J; Möbs M; Junker K; Kirfel J; Perner S; Laßmann S; Werner M; Borgmann V; Bläker H; Hummel M
    Pathologe; 2022 Mar; 43(2):126-134. PubMed ID: 34807276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
    Roma C; Rachiglio AM; Pasquale R; Fenizia F; Iannaccone A; Tatangelo F; Antinolfi G; Parrella P; Graziano P; Sabatino L; Colantuoni V; Botti G; Maiello E; Normanno N
    Cancer Biol Ther; 2016 Aug; 17(8):840-8. PubMed ID: 27261210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer.
    Lee HM; Morris V; Napolitano S; Kopetz S
    Oncology (Williston Park); 2019 Jun; 33(6):206-11. PubMed ID: 31219603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF
    Gourdin G; Chotel L; de la Fouchardière C
    Adv Ther; 2023 Aug; 40(8):3281-3290. PubMed ID: 37316651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
    Estrella JS; Tetzlaff MT; Bassett RL; Patel KP; Williams MD; Curry JL; Rashid A; Hamilton SR; Broaddus RR
    Mol Cancer Ther; 2015 Dec; 14(12):2887-95. PubMed ID: 26438153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the therapy of BRAF
    Jin Z; Sinicrope FA
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):823-829. PubMed ID: 31455117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.